BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 26164124)

  • 1. Treatment of Peripartum Cardiomyopathy: A Call to Action.
    Cardona-Guarache R; Kron J
    Can J Cardiol; 2015 Dec; 31(12):1418-20. PubMed ID: 26164124
    [No Abstract]   [Full Text] [Related]  

  • 2. The Medical Treatment of New-Onset Peripartum Cardiomyopathy: A Systematic Review of Prospective Studies.
    Desplantie O; Tremblay-Gravel M; Avram R; Marquis-Gravel G; Ducharme A; Jolicoeur EM;
    Can J Cardiol; 2015 Dec; 31(12):1421-6. PubMed ID: 26160409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An airport meeting that led to bromocriptine use in peripartum cardiomyopathy.
    Nicholls M
    Eur Heart J; 2016 Nov; 37(44):3313-3314. PubMed ID: 28007932
    [No Abstract]   [Full Text] [Related]  

  • 4. [Peripartum cardiomyopathy].
    Bretler DM; Jørgensen CH; Olesen JB; Gislason GH; Hansen PR
    Ugeskr Laeger; 2009 Jan; 171(1-2):53-5. PubMed ID: 19128569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful use of levosimendan in a patient with peripartum cardiomyopathy.
    Benlolo S; Lefoll C; Katchatouryan V; Payen D; Mebazaa A
    Anesth Analg; 2004 Mar; 98(3):822-4, table of contents. PubMed ID: 14980944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bromocriptine for the treatment of peripartum cardiomyopathy.
    Elkayam U; Goland S
    Circulation; 2010 Apr; 121(13):1463-4. PubMed ID: 20308620
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of bromocriptine in peripartum cardiomyopathy.
    Biteker M; Duran NE; Ozkan M
    Am J Obstet Gynecol; 2009 Aug; 201(2):e13; author reply e13-4. PubMed ID: 19306960
    [No Abstract]   [Full Text] [Related]  

  • 8. Indication for bromocriptine in peripartum cardiomyopathy.
    Mouquet F; Lamblin N; de Groote P
    Eur J Heart Fail; 2009 Feb; 11(2):223; author reply 223-4. PubMed ID: 19168524
    [No Abstract]   [Full Text] [Related]  

  • 9. [Patient with sudden cardiac arrest, peripartum cardiomyopathy and pulmonary embolism].
    Lewandowski A; Syska-Sumińska J; Załęska-Zydlewska I; Grzywanowska-Łaniewska I; Wsól A; Dłużniewski M
    Kardiol Pol; 2013; 71(7):741-3. PubMed ID: 23907909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripartum Cardiomyopathy Treatment with Dopamine Agonist and Subsequent Pregnancy with a Satisfactory Outcome.
    Melo MA; Carvalho JS; Feitosa FE; Araujo Júnior E; Peixoto AB; Costa Carvalho FH; Carvalho RC
    Rev Bras Ginecol Obstet; 2016 Jun; 38(6):308-13. PubMed ID: 27399926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 16-kDa prolactin and bromocriptine in postpartum cardiomyopathy.
    Hilfiker-Kleiner D; Struman I; Hoch M; Podewski E; Sliwa K
    Curr Heart Fail Rep; 2012 Sep; 9(3):174-82. PubMed ID: 22729360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caution in the use of bromocriptine in peripartum cardiomyopathy.
    Fett JD
    J Am Coll Cardiol; 2008 May; 51(21):2083; author reply 2083-4. PubMed ID: 18498970
    [No Abstract]   [Full Text] [Related]  

  • 13. ED echocardiography for peripartum cardiomyopathy.
    Chan L; Hill D
    Am J Emerg Med; 1999 Oct; 17(6):578-80. PubMed ID: 10530538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripartum cardiomyopathy - a cardiovascular disease in pregnancy and puerperium. The actual state of knowledge, challenges, and perspectives.
    Kryczka KE; Demkow M; Dzielinska Z
    Ginekol Pol; 2021; 92(2):147-152. PubMed ID: 33084016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized study.
    Hilfiker-Kleiner D; Haghikia A; Berliner D; Vogel-Claussen J; Schwab J; Franke A; Schwarzkopf M; Ehlermann P; Pfister R; Michels G; Westenfeld R; Stangl V; Kindermann I; Kühl U; Angermann CE; Schlitt A; Fischer D; Podewski E; Böhm M; Sliwa K; Bauersachs J
    Eur Heart J; 2017 Sep; 38(35):2671-2679. PubMed ID: 28934837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripartum cardiomyopathy--a new treatment option by inhibition of prolactin secretion.
    Jahns BG; Stein W; Hilfiker-Kleiner D; Pieske B; Emons G
    Am J Obstet Gynecol; 2008 Oct; 199(4):e5-6. PubMed ID: 18928969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Use of Bromocriptine for Peripartum Cardiomyopathy after Twin Delivery via Oocyte Donation.
    Morikawa N; Nakayoshi T; Yoshimura H; Watanabe M; Kumanomido J; Furusho A; Fukui D; Eto K; Nishida N; Nishihara M; A Kamiya C; Fukumoto Y
    Intern Med; 2019 Feb; 58(4):541-544. PubMed ID: 30568125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripartum cardiomyopathy.
    Bews H; Saeed M; Liu S
    CMAJ; 2021 Nov; 193(45):E1733. PubMed ID: 34782377
    [No Abstract]   [Full Text] [Related]  

  • 19. Molecular events underlying pregnancy-induced cardiomyopathy.
    Leinwand LA
    Cell; 2007 Feb; 128(3):437-8. PubMed ID: 17289564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripartum cardiomyopathy.
    Palmer DG
    J Perinat Neonatal Nurs; 2006; 20(4):324-32. PubMed ID: 17310673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.